Skip to main content

Table 2 Analysis of the hydrogen bond network in covalent complex simulations

From: Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan

 

WT

F187Y

G191A

W232R

Active site pentad and surrounding residues

 ARG314:PTR222s

97.78

98.26

97.97

98.82

 CYS329:ARG314

98.46

98.33

98.38

98.12

 LYS352:ASP353

60.41

   

 ILE355:LYS352

78.65

77.83

78.79

86.33

 ARG410:ALA406

44.55

   

 ARG410:PTR222s

99.72

99.79

99.67

99.55

 ARG410:ALA312

85.33

97.66

91.83

97.50

 ARG410:CYS451

 

41.72

 

48.01

 ALA414:ARG410

90.37

90.21

85.86

89.70

 HIS453:ALA202s

85.22

82.20

82.39

80.23

 HIS453:PTR222s

97.64

90.28

96.79

90.86

 SER214s:HIS453

93.57

93.87

87.36

92.65

 PTR222s:SER218s

76.09

65.74

66.94

67.68

Residues of point mutations and surrounding residues

 PHE(Y)187:LYS198

99.05

99.37

99.40

99.53

 GLY189:PHE(Y)187

 

80.85

69.95

64.26

 GLY197:PHE187

93.63

99.31

99.53

99.56

 HIS193:GLY(A)191

 

65.35

 

65.47

 TRP(R)242:LYS225

96.20

84.25

98.36

95.50

  1. Percentage of the hydrogen bonds established by the active site pentad with the surrounding residues (PTR stands for phosphotyrosine, while “s” following the residue number indicates that residue belongs to the small subunit)